Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZ | AMGN | GILD | CELG | VRTX |
| Company | Enzo Biochem | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1100 | 264.63 | 66.25 | 108.01 | 394.72 |
| High | 1.1125 | 267.81 | 66.72 | 108.59 | 396.98 |
| Low | 1.0700 | 260.68 | 66.16 | 107.27 | 391.25 |
| Last | 1.1100 | 268.41 | 66.46 | 108.24 | 392.27 |
| Change | -0.0200 | +5.66 | +0.30 | +0.11 | -1.21 |
| % Change | -1.77% | +2.15% | +0.45% | +0.10% | -0.31% |
| Volume | 198,328 | 1,519,952 | 4,360,028 | 191,230,496 | 708,096 |
| 20-Day Average Volume | 100,896 | 2,146,135 | 6,132,525 | 16,188,930 | 897,186 |
| Previous Close | 1.1300 | 262.75 | 66.16 | 108.13 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2140 | 272.49 | 69.88 | 108.17 | 405.43 |
| 20-Day Raw Stochastic | 17.39% | 23.96% | 6.84% | 63.25% | 4.89% |
| 20-Day Relative Strength | 31.81% | 42.26% | 29.56% | 64.69% | 36.29% |
| Weighted Alpha | -50.76 | +6.81 | -24.82 | +46.30 | +15.22 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.13% since 04/12/24 | +0.03% since 04/12/24 | -2.39% since 04/12/24 | -1.97% since 11/13/19 | -1.02% since 04/12/24 |
| Low | 1.0700 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 1.1999 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -9.76% since 03/19/24 | -1.61% since 03/19/24 | -9.49% since 03/19/24 | +5.14% since 10/18/19 | -5.47% since 03/19/24 |
| Low | 1.0700 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 1.3000 on 04/05/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -18.38% since 01/19/24 | -13.14% since 01/19/24 | -23.88% since 01/19/24 | +13.63% since 08/20/19 | -9.77% since 01/19/24 |
| Low | 1.0700 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 1.4100 on 01/22/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -16.54% since 10/19/23 | -4.72% since 10/19/23 | -15.29% since 10/19/23 | +14.14% since 05/20/19 | +7.59% since 10/19/23 |
| Low | 1.0700 on 04/19/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 1.5000 on 01/03/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 57,885 | 140,812,720 | 82,374,304 | 77,035,920 | 101,698,464 |
| Shares Outstanding, K | 51,226 | 535,919 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 31,060,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 20,290,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 8,550,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -3,060,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.75 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 06/12/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | 0.063 on 06/29/95 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 29.25 |